ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need
34 employees · est. 1981
ONA Therapeutics
First-in-class ADCs tailored to attack advanced cancer
35 employees · est. 2019 · Barcelona, Spain
ImmunoGen is the older company (1981 vs 2019).
Side-by-Side Comparison
| Metric | ImmunoGen | ONA Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1981 older | 2019 |
| Headquarters | ||
| Headquarters | Not tracked yet | Barcelona, Spain |
| Employees | ||
| Employees | 34 | 35 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Acquired | Series A |
| Total Funding | ||
| Total Funding | $681.30M | $31.50M |
| Funding Rounds | ||
| Funding Rounds | 11 | 2 |
| Services | ||
| Services | Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support | Development of first-in-class ADCs, Identification of novel cancer therapeutic targets, Biologics engineering and customization, Clinical development and trials |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers, Research Institutions | Advanced cancer patients, Clinical research institutions, Healthcare providers specializing in oncology, Pharmaceutical companies focusing on cancer treatments |
| Taxonomy | ||
| Taxonomy | Antibody-drug Conjugates, Cancer Treatment, Oncology, Immunology, Neuroscience, Therapeutics Development, Targeted Antibody Payload (TAP) Technology, Metastatic Breast Cancer, Hematological Malignancies, Solid Tumors, Collaboration Agreements, Licensing Partnerships | Antibody Drug Conjugates, Biologics Development, Cancer Therapeutics, Metastatic Cancer, Advanced Cancer, Therapeutic Biologics, Lipid Metabolism, Tumor Metastatic-Initiating Cells, Treatment Refractory Cancer, Spin-off From Research Institutes, Collaborations With Academia, Innovative Cancer Treatments, Oncology Research |
| Website | ||
| Website | immunogen.com | ona-therapeutics.com |
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while spari...
About ONA Therapeutics
ONA Therapeutics, founded in 2019 and based in Spain, is at the forefront of developing innovative solutions in the Biotechnology, Health Care, and Life Sciences industries. Utilizing their expertise in biologics, they specialize in creating first-in-class antibody drug conjugates (ADCs) designed to...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at ImmunoGen and ONA Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at ImmunoGen and ONA Therapeutics — by email.
Frequently Asked Questions
Compare ImmunoGen with someone else
Start typing a company name or domain.